Cutting Edge: Cardiac Myosin Activates Innate Immune Responses through TLRs
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Autoimmune attack on the heart is linked to host immune responses against cardiac myosin, the most abundant protein in the heart. Although adaptive immunity is required for disease, little is known about innate immune mechanisms. In this study we report that human cardiac myosin (HCM) acted as an endogenous ligand to directly stimulate human TLRs 2 and 8 and to activate human monocytes to release proinflammatory cytokines. In addition, pathogenic epitopes of human cardiac myosin, the S2 fragment peptides S2-16 and S2-28, stimulated TLRs directly and activated human monocytes. Our data suggest that cardiac myosin and its pathogenic T cell epitopes may link innate and adaptive immunity in a novel mechanism that could promote chronic inflammation in the myocardium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869 · cited 7×
“To determine TLR activation by HCM, we used HEK293 cells transfected with hTLR2, hTLR3, hTLR4, hTLR6, hTLR7, hTLR8, or hTLR9.”
BackgroundInfluentialEriksson, U., Ricci, R., Hunziker, L., Kurrer, M. O., Oudit, G. Y., Watts, T. H., Sonderegger, I., Bachmaier, K., Kopf, M., & Penninger, J. M. (2003) · Nature Medicine · doi:10.1038/nm960 · Cited by 405
Fairweather, D., Yusung, S., Frisancho, S., Barrett, M., Gatewood, S., Steele, R., & Rose, N. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4731 · Cited by 229
Mimicry and Antibody-Mediated Cell Signaling in Autoimmune Myocarditis
Li, Y., Heuser, J. S., Cunningham, L. C., Kosanke, S. D., & Cunningham, M. W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8234 · Cited by 155 · cited 2×
“In animal models of cardiac myosininduced myocarditis, pathogenic roles for CD4 T cells (3, 4) and autoantibodies (5) have been described.”
BackgroundSelf-citationEriksson, U., Kurrer, M. O., Schmitz, N., Marsch, S. C., Fontana, A., Eugster, H.-P., & Kopf, M. (2003) · Circulation · doi:10.1161/01.cir.0000043802.38699.66 · Cited by 150 · cited 1×
“In addition, IL-6 knockout mice are resistant to disease induction (14), and overexpression of TNF- resulted in severe myocarditis in susceptible mice (15).”
BackgroundFairweather, D., Frisancho-Kiss, S., Yusung, S. A., Barrett, M. A., Davis, S. E., Steele, R. A., Gatewood, S. J. L., & Rose, N. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.261 · Cited by 133
Galvin, J. E., Hemric, M. E., Kosanke, S. D., Factor, S. M., Quinn, A., & Cunningham, M. W. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64373-8 · Cited by 99
Self-citationFairweather, D., Frisancho-Kiss, S., Njoku, D. B., Nyland, J. F., Kaya, Z., Yusung, S. A., Davis, S. E., Frisancho, J. A., Barrett, M. A., & Rose, N. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3516 · Cited by 82
Li, Y., Heuser, J. S., Kosanke, S. D., Hemric, M., & Cunningham, M. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3225 · Cited by 73 · cited 4×
“Innate immune cells, including macrophages, neutrophils, and dendritic cells (9–11), and several cytokines, including IL-6, IL-1, and TNF- , are present in an inflamed myocardium (9, 12, 13).”
BackgroundInfluentialSelf-citation
Cited by
The role of oxidative stress during inflammatory processes
Lugrin, J., Rosenblatt-Velin, N., Parapanov, R., & Liaudet, L. (2014) · Biological Chemistry · doi:10.1515/hsz-2013-0241 · Cited by 737
Kociol, R. D., Cooper, L. T., Fang, J. C., Moslehi, J. J., Pang, P. S., Sabe, M. A., Shah, R. V., Sims, D. B., Thiene, G., Vardeny, O., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000745 · Cited by 625
Endogenous toll‐like receptor ligands and their biological significance
Yu, L., Wang, L., & Chen, S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01127.x · Cited by 532
Endogenous ligands of TLR2 and TLR4: agonists or assistants?
Erridge, C. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1209775 · Cited by 518
The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy
Heymans, S., Eriksson, U., Lehtonen, J., & Cooper, L. T. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.937 · Cited by 359
Innate immune signaling in cardiac ischemia
Arslan, F., de Kleijn, D. P., & Pasterkamp, G. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.38 · Cited by 347
Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity
Suurmond, J., & Diamond, B. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78084 · Cited by 337
Brun, P., Giron, M. C., Qesari, M., Porzionato, A., Caputi, V., Zoppellaro, C., Banzato, S., Grillo, A. R., Spagnol, L., De Caro, R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.047 · Cited by 300
Inflammatory Cardiomyopathic Syndromes
Trachtenberg, B. H., & Hare, J. M. (2017) · Circulation Research · doi:10.1161/circresaha.117.310221 · Cited by 289
“release of cardiac myosin from damaged cardiomyocytes acts as a ligand for TLRs and stimulates an ongoing innate inflammatory response.(21) B-cell activation and cardiac autoantibodies (ie, to myosin or β1 adrenergic receptors) contribute to ongoing myocardial inflammation,(22) especially if there is persistence of vi…”
BackgroundDAMPs as mediators of sterile inflammation in aging-related pathologies
Feldman, N., Rotter-Maskowitz, A., & Okun, E. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.01.003 · Cited by 283
“…Biglycan (Schaefer et al., 2005), HMGB1 (Yu et al., 2006), HSP60 (Zanin-Zhorov et al., 2003), HSP70 (Vabulas et al., 2002a), human cadiac myosin (Zhang et al., 2009), LMW-HA (Scheibner et al., 2006), MSU crystals (Liu-Bryan et al., 2005), Gp96 (Warger et al., 2006), H D-3 (Guo et al., 2013),…”
BackgroundInfluentialImmune checkpoint inhibitor–associated myocarditis: manifestations and mechanisms
Moslehi, J., Lichtman, A. H., Sharpe, A. H., Galluzzi, L., & Kitsis, R. N. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145186 · Cited by 237
“Moreover, in addition to functioning as an antigen, myosin has been shown to function as a damage-associated molecular pattern (155, 159).”
BackgroundCardiac myosin-Th17 responses promote heart failure in human myocarditis
Myers, J. M., Cooper, L. T., Kem, D. C., Stavrakis, S., Kosanke, S. D., Shevach, E. M., Fairweather, D., Stoner, J. A., Cox, C. J., & Cunningham, M. W. (2016) · JCI Insight · doi:10.1172/jci.insight.85851 · Cited by 230
“Previously, cardiac myosin and its specific peptides have been shown by siRNA knockdown to function as endogenous TLR ligands for normal human CD14+ monocytes (4).”
InfluentialSelf-citationComplexities in the Relationship Between Infection and Autoimmunity
Root-Bernstein, R., & Fairweather, D. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-013-0407-3 · Cited by 98
Martens, P., Cooper, L. T., & Tang, W. H. W. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.031454 · Cited by 76
Roberts, B. J., Dragon, J. A., Moussawi, M., & Huber, S. A. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-25 · Cited by 54
“A recent study has shown that cardiac myosin acts as an endogenous ligand for TLR2 and 8 and stimulates dendritic cells in vitro to release pro-inflammatory cytokines [38].”
BackgroundRole of Toll-Like Receptors and Th Responses in Viral Myocarditis
Zheng, S.-Y., & Dong, J.-Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843891 · Cited by 27
Heart Rate After Cardiac Transplantation—Lessons From the Tortoise and the Shrew
Critchley, W. R., Yonan, N., Shaw, S. M., & Fildes, J. E. (2013) · Transplantation Journal · doi:10.1097/tp.0b013e31826bc42a · Cited by 13
“Indeed, debilitating myosin-specific immune activation has been previously observed (50).”
Background
Metadata
- Authors
- Zhang, P., Cox, C. J., Alvarez, K. M., & Cunningham, M. W.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-07-01
- Volume
- 183
- Issue
- 1
- Pages
- 27-31
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1696589853
- Cited by
- 112
- References
- 9
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.